Pmst1 mutants for chemoenzymatic synthesis of sialyl lewis x compounds
US-2017204381-A1 · Jul 20, 2017 · US
US11739305B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11739305-B2 |
| Application number | US-201816955737-A |
| Country | US |
| Kind code | B2 |
| Filing date | Dec 21, 2018 |
| Priority date | Dec 21, 2017 |
| Publication date | Aug 29, 2023 |
| Grant date | Aug 29, 2023 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
α2-6-Sialyltransferase (2,6ST) variants having improved α2-6-specific sialidase activity as compared to the native 2,6ST enzymes are described. The variants include GT80 sialyltransferases such as P. damselae Pd2,6ST. Methods for making de-sialylated products and screening sialidase activity are also described.
Opening claim text (preview).
What is claimed is: 1. An α2-6-sialyltransferase (2,6ST) variant having increased α2-6-specific sialidase catalytic efficiency (k cat /K M ) as compared to a native 2,6ST, wherein the 2,6ST variant comprises an amino acid sequence having at least 90% amino acid sequence identity to the amino acid sequence of SEQ ID NO:2 and comprising one or more of: a leucine residue at a position corresponding to residue 232 of SEQ ID NO: 1; a serine residue at a position corresponding to residue 356 of SEQ ID NO: 1; and a phenylalanine residue at a position corresponding to residue 361 of SEQ ID NO: 1. 2. The 2,6ST variant of claim 1 , wherein the 2,6ST variant comprises: the leucine residue at the position corresponding to residue 232 of SEQ ID NO: 1; the serine residue at the position corresponding to residue 356 of SEQ ID NO: 1; and the phenylalanine residue at the position corresponding to residue 361 of SEQ ID NO: 1. 3. The 2,6ST variant of claim 1 , wherein the 2,6ST variant comprises an amino acid sequence having at least 95% sequence identity to the amino acid sequence of SEQ ID NO:2. 4. The 2,6ST variant of claim 1 , wherein the 2,6ST variant comprises an amino acid sequence having at least 98% sequence identity to the amino acid sequence of SEQ ID NO:2. 5. An isolated nucleic acid encoding the 2,6ST variant according to claim 1 . 6. A vector comprising the nucleic acid of claim 5 . 7. An Escherichia coli host cell comprising the nucleic acid of claim 5 .
transferring other glycosyl groups (2.4.99) · CPC title
Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression · CPC title
Beta-galactoside alpha-2,6-sialyltransferase (2.4.99.1) · CPC title
Beta-galactoside alpha-2,3-sialyltransferase (2.4.99.4) · CPC title
Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.